Blog

/Blog
Blog2019-08-20T10:39:44-05:00

Categories

Recent Posts

Archives

FDA Approves Genentech’s Rozlytrek (entrectinib) for ROS1 Non-Small Cell Lung Cancer (NSCLC) and NTRK-Driven Tumors

August 16th, 2019|Hot Topics, News|

On August 15, 2019 the U.S. Food and Drug Administration approved Rozlytrek (entrectinib) for the treatment of patients with ROS1-positive, metastatic non-small cell lung cancer. It was also simultaneously approved for the treatment of patients with any solid tumor that is NTRK fusion-positive, following progression on other therapies. This [...]

GO2 Foundation Presents 2019 Bonnie J. Addario Lectureship Award at ILCC

August 2nd, 2019|Hot Topics, News|

GO2 Foundation for Lung Cancer is pleased to announce that it presented Solange Peters, MD, PhD, with the 2019 Bonnie J. Addario Lectureship Award for her emphasis on groundbreaking biomarker research, improving access to care for lung cancer patients worldwide, and supporting the advancement of women in oncology. GO2 Foundation honored [...]

Make an Impact from Home, 7/23!

July 16th, 2019|News|

On July 23, over 130 advocates will meet with elected officials on Capitol Hill to advocate for the lung cancer community at the GO2 Foundation National Advocacy Summit. Now you have the opportunity to strengthen the collective voice and ignite change—without leaving your home! Join us on July 23 [...]

Lung Cancer Stigma’s Harmful Consequences

July 10th, 2019|Hot Topics|

Despite increased awareness around lung cancer in recent years, the stigma associated with the disease remains an issue for the lung cancer community. Beyond the known psychosocial issues associated with this stigma, our research has revealed that both patients and oncologists feel that the stigma can actually affect the level of care [...]

Going the Extra Mile: Jason’s Story

July 9th, 2019|Hot Topics|

Losing a loved one to lung cancer is a pain that no one should have to experience. After Jason’s mother passed away from lung cancer in May 2018, he committed to doing something positive in her honor. On November 3, he’ll be running in the 2019 New York City Marathon [...]

Patient Needs Represented on The Hill

July 9th, 2019|Hot Topics|

This week, The Hill hosted an event on Cost, Quality and Care: The Medicare Equation, where experts gathered to discuss the balancing act between Medicare affordability and quality of care. Our Co-founder, President, and CEO, Laurie Fenton Ambrose, brought the patient voice to the discussion. “Just addressing the cost of [...]

Early Screening Equals Early Diagnosis

June 18th, 2019|Hot Topics, News|

GO2 Foundation for Lung Cancer’s recently published scientific paper found that lung cancer screening programs can successfully detect lung cancer early with the majority of lung cancers diagnosed at stage 1 or limited stage. Importantly, outcomes at academic and nonacademic sites were compared and the data confirmed that responsible [...]

Research Wins Big

May 7th, 2019|News|

The GO2 Foundation for Lung Cancer is honored to announce that on May 2 two of our programs received Your Cancer’s Cancer Community (C2) Awards. These awards celebrate “the unsung heroes of cancer care” – individuals and organizations that advance cancer care and work to improve the lives of [...]